1. |
IDF Clinical Guidelines Task Force. Global guideline for type 2 diabetes:recommendations for standard, comprehensive, and minimal care[J]. Diabet Med, 2006, 23(6):579-593.
|
2. |
Shank ML, Del PS, DeFronzo RA. Bedtime insulin/daytime glipizide. Effective therapy for sulfonylurea failures in NIDDM[J]. Diabetes, 1995, 44(2):165-172.
|
3. |
Riddle MC. Evening insulin strategy[J]. Diabetes Care, 1990, 13(6):676-686.
|
4. |
Taskinen MR, Sane T, Helve E, et al. Bedtime insulin for suppression of overnight free-fatty acid, blood glucose, and glucose production in NIDDM[J]. Diabetes, 1989, 38(5):580-588.
|
5. |
卜石, 郭晓惠, 杨文英, 等. 预混胰岛素转为基础胰岛素联合口服降糖药治疗方案的2型糖尿病患者临床特征分析[J]. 中华医学杂志, 2007, 87(44):3115-3118.
|
6. |
杨文英, 纪立农, 陆菊明, 等. 中国α型糖尿病防治指南(2010年版)[J]. 中国糖尿病杂志, 2012, 20(1):S1-S37.
|
7. |
Mulnier HE, Seaman HE, Raleigh VS, et al. Mortality in people with type 2 diabetes in the UK[J]. Diabet Med, 2006, 23(5):516-521.
|
8. |
Ridderstråle M, Gudbjörnsdottir S, Eliasson B, et al. Obesity and cardiovascular risk factors in type 2 diabetes:results from the Swedish National Diabetes Register[J]. J Intern Med, 2006, 259(3):314-322.
|
9. |
Hammer H, Klinge A. Patients with type 2 diabetes inadequately controlled on premixed insulin:effect of initiating insulin glargine plus oral antidiabetic agents on glycaemic control in daily practice[J]. Int J Clin Pract, 2007, 61(12):2009-2018.
|
10. |
JRaskin P, Allen E, Hollander P, et al. Initiating insulin therapy in type 2 diabetes:a comparison of biphasic and basal insulin analoges[J]. Diabetes Care, 2005, 28(2):260-265.
|
11. |
Janka HU, Plewe G, Riddle MC, et al. Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes[J]. Diabetes Care, 2005, 28(2):254-259.
|